The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ünlü C.

Otdelenie akusherstva i ginekologii universiteta Adzhibadema gospitalia Bakirkoĭ, Stambul, Turtsiia

Donders G.

Otdelenie akusherstva i ginekologii regional'nogo gospitalia Kheĭlig Khart Tienen, gospital' Universiteta Gastuisberg Leven, i gospital' Universiteta Tsitadel' L'ezh, L'ezh, Bel'giia

Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem (expanded abstract)

Authors:

Ünlü C., Donders G.

More about the authors

Read: 2178 times


To cite this article:

Ünlü C, Donders G. Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem (expanded abstract). Russian Bulletin of Obstetrician-Gynecologist. 2012;12(6):46‑48. (In Russ.)

Recommended articles:
Probiotics in the treatment and prevention of vagi­nitis in pregnant women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):22-26
Evaluation of prognostic factors of preterm birth. Russian Journal of Human Reproduction. 2025;(2):37-43

References:

  1. Abad C.L., Safdar N. The role of lactobacillus probiotics in the treat­ment or prevention of urogenital infections - a systematic review. J Chemother 2009; 21: 243-52.
  2. Barbes C., Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 1999; 13: 747-751.
  3. Boris S., Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000; 2: 543-546.
  4. Donders G.G., Van Bulck B., Van de Walle P., Kaiser R.R., Pohlig G., Gonser S. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor) on vaginitis and vaginosis with disrupted vaginal microflora: A Multicenter, randomized, single-blind, active-controlled pilot study. Gynec Obstet Invest 2010; 70: 264-272.
  5. Englund D.E., Elamsson K.B., Johansson E.D.B. Bioavailability of oes­triol. Acta Endocrinol (Copenh) 1982; 99: 136-140.
  6. Eschenbach D.A., Davick P.R., Williams B.L., Klebanoff S.J., Young-Smith K., Critchlow C.M. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27: 251-256.
  7. Fredricks D.N. Molecular methods to describe the spectrum and dynamics of the vaginal microbiota. Anaerobe 2011; 17: 191-195.
  8. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-1911.
  9. Head K.A. Estriol: safety and efficacy. Altern Med Rev 1998; 3: 101-113.
  10. Horvath B., Hadarits F., Szabo L., Serenyi P., Godo G. Probiotic treat­ment of vaginal infections. A prospective study of the treatment of 144 patient with Gynoflor vaginal tablets. Journal of Hungarian Association for Obstetrics and Gynecology [Magyar Nöorv.Labj] 2004; 67: 85-91.
  11. Hoyme U.B., Grosch A., Roemer V.M., Saling E. Erste Resultate der Erfurter Frühgeburten-Vermeidungs-Aktion. Zeitschrift für Geburtshilfe & Neonatologie 1998; 6: 247-250.
  12. Kanne B., Beyerle-Müller H.L., Patz B., Wackerle L. Die antibiotische Aktivität der Döderleinflora zur lokalen Behandlung vaginaler Infektionen mit lebensfähigen Döderleinkeimen und Estriol. Jatros Gynäkologie 1986; 2: 3-28.
  13. Keller PJ, Riedmann R, Fischer M. Estrone, estradiol and estriol content after intravaginal application of estriol in postmenopause. Gynäkol Rundsch 1980; 20: 77-79.
  14. Lamont R.F., Sobel J.D., Akins R.A., Hassan S.S., Chaiworapongsa T., Kusanovic J.P. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011; 118: 533-349.
  15. Larsson P.G., Stray-Pedersen B., Ryttig K.R., Larsen S. Human lactoba­cilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, ran­domized, placebo-controlled study. BMC Womens Health 2008; 8: 3.
  16. Larsson P.G., Brandsborg E., Forsum U., Pendharkar S., Andersen K.K., Nasic S. Extended antimicrobial treatment of bacterial vagi­nosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis 2011; 11: 223.
  17. Lauritzen C., Graf F., Mucha M. Restoration of the physiological vagi­nal environment with Doederlein bacteria and estriol. Frauenarzt 1984; 4.
  18. Melczer Z., Langmar Z., Paulin F. Experience with local ecotherapy in the treatment of bacterial vaginosis in pregnant and non-preg­nant women. Journal of Hungarian Association for Obstetrics and Gynecology [Magyar Nöorv.Labj] 2002; 65: 319-323.
  19. Ozkinay E., Terek M.C., Yayci M., Kaiser R., Grob P., Tuncay G. The effectiveness of live lactobacilli in combination with low dose oes­triol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 2005; 112: 234-240.
  20. Parent D., Bossens M., Bayot D., Kirkpatrick C., Graf F., Wilkinson F.E. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol. Arzneimittelforschung 1996; 46: 68-73.
  21. Redondo-Lopez V., Cook R.L., Sobel J.D. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990; 12: 856-872.
  22. Reid G., Younes J.A., van der Mei H.C., Gloor G.B., Knight R., Busscher H.J. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011; 9: 27-38.
  23. Reid G., Bruce A.W. Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001; 183: 77-80.
  24. Schöni M., Graf F., Meier B. Behandlung von Vaginalstörungen mit Döderlein-Keimen. SAZ 1988; 126: 139-142.
  25. Tatarchuk T.F., Zacharenko N.F., Kosey N.V., Suhorebraya E.I. Function of vaginal ecosystem in postoperative complications prophylaxis. "Women Reproductive Health" (WHR) 2006; 4.
  26. Unzeitig V., Al Awad H. New options of stabilization of disturbed vagi­nal environment balance. Prakticka Gynekologia 2006; 10: 170-173.
  27. Witkin S.S., Linhares I.M., Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 2007; 21: 347-354.
  28. Witkin S.S., Linhares I.M., Giraldo P., Ledger W.J. An altered immunity hypothesis for the development of symptomatic bacterial vagino­sis. Clin Infect Dis 2007; 44: 554-337.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.